VTE: 2018 treatment guidelines

Dr Mark Crowther is a professor and chair of the Department of Medicine and the Leo Pharma Chair in Thromboembolism Research at McMaster University.

See also

VTE: 2018 ASH diagnostic guidelines A lecture by Dr Wendy Lim, from McMaster University, Canada, delivered at McMaster International Review Course in Internal Medicine (MIRCIM) in May 2019.
VTE: 2018 ASH prevention guidelines A lecture by Dr Susan Kahn, from McGill University, Canada, delivered at McMaster International Review Course in Internal Medicine (MIRCIM) in May 2019.
COVID-19: To treat or not to treat? May 15 update Dr Mark Crowther, chair of the Department of Medicine at McMaster University and past president of the Anticoagulation Forum, offers an expert overview of our current understanding of thrombosis and anticoagulation in patients with COVID-19.
Diagnosis and management of increased ferritin A lecture by Dr Mark Crowther, from McMaster University, Canada, delivered at McMaster International Review Course in Internal Medicine (MIRCIM) in May 2019.
Diagnostic workup of suspected DVT What should be the diagnostic workup in a patient with suspected deep vein thrombosis (DVT)?
Perioperative management of anticoagulation around the time of low-bleeding-risk procedures Dr James Douketis, professor in the Division of Hematology and Thromboembolism at McMaster University and president of Thrombosis Canada, talks about perioperative anticoagulant management around low-risk procedures.
Heparin in the management of VTE Is there still a place for unfractionated heparin and low-molecular-weight heparin (LMWH) in the current management of venous thromboembolism (VTE)? When to use them?
Antiplatelet treatment in patients on long-term anticoagulation What is the best approach to antiplatelet treatment in patients on long-term anticoagulation?

VTE: 2018 treatment guidelines

Social Media